DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Chapple C, Steers W, Norton P, Millard R, Kradillis G, Glavind K, Abrams P.
A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder.
BJU 2005; 95: 993-1001
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.